Your browser doesn't support javascript.
loading
Potential Neuroprotective Effect of Cannabinoids in COVID-19 Patients.
Cortes-Altamirano, José Luis; Yáñez-Pizaña, Ariadna; Reyes-Long, Samuel; Angélica, González-Maciel; Bandala, Cindy; Bonilla-Jaime, Herlinda; Alfaro-Rodríguez, Alfonso.
Afiliação
  • Cortes-Altamirano JL; Division de Neurociencias, Instituto Nacional de Rehabilitación, Secretaría de Salud, Mexico City, 14389, Mexico.
  • Yáñez-Pizaña A; Departamento de Quiropráctica, Universidad Estatal del Valle de Ecatepec, Estado de Mexico, 55210, Mexico.
  • Reyes-Long S; Escuela de Ciencias de la Salud, Medicina Veterinaria y Zootecnia, Universidad del Valle de Mexico, Mexico City, 04910, México.
  • Angélica GM; Escuela de Medicina Veterinaria y Zootecnia en Pequeñas Especies, Federación Canofila Mexicana, Mexico City, 14430, México.
  • Bandala C; Division de Neurociencias, Instituto Nacional de Rehabilitación, Secretaría de Salud, Mexico City, 14389, Mexico.
  • Bonilla-Jaime H; Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City, 07738, México.
  • Alfaro-Rodríguez A; Laboratory of Cell and Tissue Morphology, Instituto Nacional de Pediatría, Secretaría de Salud, Insurgentes Sur No. 3700-C, Mexico City, C. P. 04530, Mexico.
Curr Top Med Chem ; 22(16): 1326-1345, 2022.
Article em En | MEDLINE | ID: mdl-35382723
The global pandemic caused by the SARS-CoV-2 virus began in early 2020 and is still present. The respiratory symptoms caused by COVID-19 are well established. However, neurological manifestations that may result from direct or indirect neurological damage after SARS-CoV-2 infection have been reported frequently. The main proposed pathophysiological processes leading to neurological damage in COVID-19 are cerebrovascular disease and indirect inflammatory/ autoimmune origin mechanisms. A growing number of studies confirm that neuroprotective measures should be maintained in COVID-19 patients. On the other hand, cannabinoids have been the subject of various studies that propose them as potentially promising drugs in chronic neurodegenerative diseases due to their powerful neuroprotective potential. In this review, we addresses the possible mechanism of action of cannabinoids as a neuroprotective treatment in patients infected by SARS-CoV-2. The endocannabinoid system is found in multiple systems within the body, including the immune system. Its activation can lead to beneficial results, such as a decrease in viral entry, a reduction of viral replication, and a reduction of pro-inflammatory cytokines such as IL-2, IL-4, IL-6, IL-12, TNF-α, or IFN-c through CB2R expression induced during inflammation by SARS-CoV-2 infection in the central nervous system.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canabinoides / Fármacos Neuroprotetores / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: Curr Top Med Chem Assunto da revista: QUIMICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: México País de publicação: Emirados Árabes Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canabinoides / Fármacos Neuroprotetores / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: Curr Top Med Chem Assunto da revista: QUIMICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: México País de publicação: Emirados Árabes Unidos